A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults.

@article{Duthie2019AP1,
  title={A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults.},
  author={Malcolm S. Duthie and Aude Frevol and Tracey A Day and Rhea N Coler and Julie A Vergara and Tom Rolf and Zachary K. Sagawa and Anna Marie Beckmann and Corey Casper and Steven G. Reed},
  journal={Vaccine},
  year={2019}
}
Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant
TLDR
Results indicate that this innovative vaccine formulation confers protection against L. infantum infection, supporting the advancement of the vaccine formulation into process development and manufacturing and the conduction of toxicity studies towards future phase I human clinical trials.
Leprosy: what is new
TLDR
The recent evidence supporting theories of zoonotic transmission from armadillos and the less‐discussed Eurasian red squirrels has emerged and knowledge on genetic polymorphisms that may increase leprosy susceptibility, such as the newly uncovered mitochondrial ribosomal protein S5 (MRPS5) polymorphism in the Chinese population, is outlined.
An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21
TLDR
QS21-free, gE/SLA-SE is a promising candidate for development of gE-based HZ vaccines with high immunogenicity—particularly when targeting an older population.
Detection and Monitoring of Mycobacterium leprae Infection in Nine Banded Armadillos (Dasypus novemcinctus) Using a Quantitative Rapid Test
TLDR
The results show that serum levels of anti-PGL-I IgM, and to a lesser extent IgG, significantly increase soon after experimental M. leprae infection in armadillos, and this animal model can provide useful insight into antibody kinetics in early infection in the various spectral forms of human leprosy.
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
TLDR
It is shown that mRNA-LNP immunization compared to protein immunization elicits either the same or superior magnitude and breadth of HIV-1 Env-specific polyfunctional antibodies.
Susceptibility and resistance in leprosy: Studies in the mouse model
  • L. Adams
  • Biology, Medicine
    Immunological reviews
  • 2021
TLDR
The generation of immunosuppressed and genetically engineered mice has since offered more tools for the study of the M. leprae–induced granuloma, and these new mouse models have provided insights into the immunoregulatory mechanisms responsible for the spectrum of this complex disease.
Mycobacterial skin infection
TLDR
Mycobacterial cutaneous lesions are nonpathognomonic and clinical suspicion must be confirmed by culture or molecular detection, and long-course multidrug treatment is required based on susceptibility tests.
Treatment and Evaluation Advances in Leprosy Neuropathy
  • G. Ebenezer, D. Scollard
  • Medicine, Biology
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
  • 2021
TLDR
A variety of established as well as new methods for the early diagnosis and assessment of leprosy neuropathy are reviewed and a candidate vaccine has shown apparent benefit in preventing nerve injury in the armadillo model.
Insights into Mycobacterium leprae Proteomics and Biomarkers—An Overview
TLDR
Light is shed on the knowledge gained to understand leprosy or its pathogen employing proteomics and its role in diagnosis to help in better understanding the pathogenesis.
...
...

References

SHOWING 1-10 OF 46 REFERENCES
Mycobacterium leprae Recombinant Antigen Induces High Expression of Multifunction T Lymphocytes and Is Promising as a Specific Vaccine for Leprosy
TLDR
The data suggest that these multifunctional antigen-specific T cells provide a more effective response against M. leprae infection that prevents the development of leprosy.
Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.
TLDR
A delayed third fractional vaccine dose improved immunogenicity and protection against infection and Optimization of the RTS,S/AS01 immunization regimen may lead to improved approaches against malaria.
A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates
TLDR
The remarkable plasticity of MVA opens the road to development of a novel class of highly complex recombinant TB vaccines to be evaluated in both prophylactic and therapeutic settings.
Impact of PGL-I Seropositivity on the Protective Effect of BCG Vaccination among Leprosy Contacts: A Cohort Study
TLDR
The finding that rates of leprosy cases were highest among seropositive contacts justifies targeting this specific group for close monitoring, and it is recommended that PGL-I-positive contacts and contacts with a high familial bacteriological index, regardless of serological response, should be monitored.
Making of a highly useful multipurpose vaccine
TLDR
MiP expediated bacterial clearance and shortened the recovery time of leprosy patients and converted 65-70% of lepromin negative BL, LL patients to lePromin positivity status, which is not achieved by treatment with, drugs alone.
From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE
TLDR
The vaccine candidate was shown to be safe and induced a strong antigen‐specific immune response, as evidenced by cytokine and immunoglobulin subclass data, which provide a strong rationale for additional trials in Leishmania‐endemic countries in populations vulnerable to VL.
Utility of recombinant proteins LID-1 and PADL in screening for Mycobacterium leprae infection and leprosy.
TLDR
The data indicate the utility of the LID-1 and PADL antigens as primary screening tools for the detection of M. leprae infection and identification of leprosy patients and the follow-up of seropositive subjects could clarify the predictive value and utility of detecting anti-LID- 1 and P ADL antibodies within leproSy control programs.
...
...